Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$71.58 - $87.29 $668,771 - $815,550
-9,343 Closed
0 $0
Q1 2024

May 15, 2024

BUY
$71.58 - $87.29 $156,760 - $191,165
2,190 Added 30.62%
9,343 $684,000
Q4 2023

Feb 13, 2024

BUY
$73.27 - $83.09 $318,358 - $361,026
4,345 Added 154.74%
7,153 $579,000
Q2 2023

Aug 10, 2023

SELL
$76.01 - $86.7 $1,292 - $1,473
-17 Reduced 0.6%
2,808 $216,000
Q1 2023

May 12, 2023

SELL
$77.31 - $88.08 $35,562 - $40,516
-460 Reduced 14.0%
2,825 $235,000
Q4 2022

Feb 13, 2023

SELL
$62.32 - $89.47 $3,926 - $5,636
-63 Reduced 1.88%
3,285 $282,000
Q3 2022

Nov 14, 2022

SELL
$59.54 - $68.01 $84,308 - $96,302
-1,416 Reduced 29.72%
3,348 $206,000
Q2 2022

Aug 12, 2022

SELL
$57.72 - $65.01 $29,437 - $33,155
-510 Reduced 9.67%
4,764 $295,000
Q1 2022

May 13, 2022

SELL
$57.92 - $72.58 $104,661 - $131,152
-1,807 Reduced 25.52%
5,274 $313,000
Q4 2021

Feb 14, 2022

BUY
$64.88 - $73.64 $3,827 - $4,344
59 Added 0.84%
7,081 $515,000
Q3 2021

Nov 12, 2021

SELL
$67.69 - $73.03 $7,378 - $7,960
-109 Reduced 1.53%
7,022 $491,000
Q2 2021

Aug 17, 2021

BUY
$63.47 - $69.35 $64,358 - $70,320
1,014 Added 16.58%
7,131 $491,000
Q1 2021

May 13, 2021

BUY
$60.0 - $68.46 $131,220 - $149,722
2,187 Added 55.65%
6,117 $395,000
Q4 2020

Feb 12, 2021

BUY
$56.65 - $64.55 $222,634 - $253,681
3,930 New
3,930 $227,000
Q3 2020

Nov 13, 2020

SELL
$62.1 - $78.08 $201,949 - $253,916
-3,252 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$72.34 - $84.0 $235,249 - $273,168
3,252 New
3,252 $250,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $83.6B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Geo Wealth Management, LLC Portfolio

Follow Geo Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geo Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geo Wealth Management, LLC with notifications on news.